Middle East & Africa Opioids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East & Africa Opioids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Opioids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East & Africa Opioids Market Regional Analysis

6.2 Middle East & Africa Opioids Market Revenue 2020-2030 (US$ Million)

6.3 Middle East & Africa Opioids Market Forecast Analysis

7. Middle East & Africa Opioids Market Analysis – by Product

7.1 Immediate Release Short Acting Opioid

7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Extended Release Long Acting Opioid

7.2.1 Overview
7.2.2 Extended Release Long Acting Opioid: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Middle East & Africa Opioids Market Analysis – by Application

8.1 Pain Management

8.1.1 Overview
8.1.2 Pain Management: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Anesthesia

8.2.1 Overview
8.2.2 Anesthesia: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Diarrhea Suppression

8.3.1 Overview
8.3.2 Diarrhea Suppression: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.4 Cough Suppression

8.4.1 Overview
8.4.2 Cough Suppression: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.5 De-Addiction

8.5.1 Overview
8.5.2 De-Addiction: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Middle East & Africa Opioids Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Transdermal Patch

9.3.1 Overview
9.3.2 Transdermal Patch: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Middle East & Africa Opioids Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview
10.2.2 Retail Pharmacies: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Middle East & Africa Opioids Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa

11.2.1 Middle East & Africa Opioids Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Middle East & Africa Opioids Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South Africa: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 South Africa: Middle East & Africa Opioids Market Breakdown, by Product
11.2.1.1.2 South Africa: Middle East & Africa Opioids Market Breakdown, by Application
11.2.1.1.3 South Africa: Middle East & Africa Opioids Market Breakdown, by Route of Administration
11.2.1.1.4 South Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

11.2.1.2 Saudi Arabia: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Product
11.2.1.2.2 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Application
11.2.1.2.3 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Route of Administration
11.2.1.2.4 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

11.2.1.3 UAE: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 UAE: Middle East & Africa Opioids Market Breakdown, by Product
11.2.1.3.2 UAE: Middle East & Africa Opioids Market Breakdown, by Application
11.2.1.3.3 UAE: Middle East & Africa Opioids Market Breakdown, by Route of Administration
11.2.1.3.4 UAE: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

11.2.1.4 Rest of Middle East and Africa: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Product
11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Application
11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Route of Administration
11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Neuraxpharm Pharmaceuticals SL

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Endo International plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Hikma Pharmaceuticals Plc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Mallinckrodt Plc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Rusan Pharma Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Teva Pharmaceutical Industries Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Middle East & Africa Opioids Market